中 文  |  English
 
  • Home
  • About us
    • About Viva
    • Company Culture
    • Management Team
    • Scientific Advisory Board
    • Investors and Board of Directors
    • Careers
  • Services
    • Service Overview
    • Gene–to-Protein & Gene–to-Structure
    • GPCR Targeted Discovery Programs
    • Fragment Based Lead Generation
    • High Level Medicinal Chemistry
    • In Vivo Models
    • In Vitro Pharmacology
    • Antibody Therapeutics Discovery
    • Protein Analysis
    • DMPK
  • News & events
    • What's New
    • In the News
    • Events
  • Project management
    • Log in
    • Contact CS manager
  • Contact us
    • Contact us
    • Online inquiry
  • Viva Biotech Contributes to Breakthrough Drug Discovery Research Works Published Recently in the “Biochemistry” and the “Chemistry & Biology”
  • Viva Biotech Appoints Dr. Taiping Chen as VP of In Vivo Pharmacology
  • Addex Partners with Viva Biotech to Advance Allosteric Modulators Targeting Adenosine 2A Receptor
  • Gene-to-Structure and Gene-to-Protein
  • GPCR Targeted Discovery Programs
  • Fragment Based Lead Generation
  • High Level Medicinal Chemistry
  • Antibody Therapeutic Discovery Using Phage Display

 

网站制作：炙阳科技Copyright © Viva Biotech Ltd. All Rights Reserved 沪ICP备12042930号